105 related articles for article (PubMed ID: 17082795)
1. A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer.
Frau E; Magnon C; Opolon P; Connault E; Opolon D; Beermann F; Abitbol M; Perricaudet M; Bouquet C
Cancer Gene Ther; 2007 Mar; 14(3):251-61. PubMed ID: 17082795
[TBL] [Abstract][Full Text] [Related]
2. High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts.
Joseph JM; Bouquet C; Opolon P; Morizet J; Aubert G; Rössler J; Gross N; Griscelli F; Perricaudet M; Vassal G
Cancer Gene Ther; 2003 Nov; 10(11):859-66. PubMed ID: 14605672
[TBL] [Abstract][Full Text] [Related]
3. Development of lentiviral vectors for antiangiogenic gene delivery.
Shichinohe T; Bochner BH; Mizutani K; Nishida M; Hegerich-Gilliam S; Naldini L; Kasahara N
Cancer Gene Ther; 2001 Nov; 8(11):879-89. PubMed ID: 11773978
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of a recombinant adenovirus encoding a HSA-Angiostatin kringle 1-3 conjugate inhibits MDA-MB-231 tumor growth and metastasis in a transgenic model of spontaneous eye cancer.
Bouquet C; Frau E; Opolon P; Connault E; Abitbol M; Griscelli F; Yeh P; Perricaudet M
Mol Ther; 2003 Feb; 7(2):174-84. PubMed ID: 12597905
[TBL] [Abstract][Full Text] [Related]
6. In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy.
Le Gat L; Gogat K; Bouquet C; Saint-Geniez M; Darland D; Van Den Berghe L; Marchant D; Provost A; Perricaudet M; Menasche M; Abitbol M
Gene Ther; 2003 Dec; 10(25):2098-103. PubMed ID: 14595383
[TBL] [Abstract][Full Text] [Related]
7. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis.
Apparailly F; Bouquet C; Millet V; Noel D; Jacquet C; Opolon P; Perricaudet M; Sany J; Yeh P; Jorgensen C
Gene Ther; 2002 Feb; 9(3):192-200. PubMed ID: 11859422
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of metastatic brain tumor growth by intramuscular administration of the endostatin gene.
Oga M; Takenaga K; Sato Y; Nakajima H; Koshikawa N; Osato K; Sakiyama S
Int J Oncol; 2003 Jul; 23(1):73-9. PubMed ID: 12792778
[TBL] [Abstract][Full Text] [Related]
12. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
Isayeva T; Chanda D; Kallman L; Eltoum IE; Ponnazhagan S
Cancer Res; 2007 Jun; 67(12):5789-97. PubMed ID: 17575146
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model.
Li YY; Qian GS; Huang GJ; Chen F; Qian P; Yu SC; Wang CZ; Li Q; Wang JC; Wu GM
Cancer J; 2006; 12(2):136-46. PubMed ID: 16630405
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
[TBL] [Abstract][Full Text] [Related]
15. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
[TBL] [Abstract][Full Text] [Related]
17. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
[TBL] [Abstract][Full Text] [Related]
18. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.
Li X; Liu YH; Lee SJ; Gardner TA; Jeng MH; Kao C
Clin Cancer Res; 2008 Jan; 14(1):291-9. PubMed ID: 18172281
[TBL] [Abstract][Full Text] [Related]
19. Combined antiestrogen, antiangiogenic and anti-invasion therapy inhibits primary and metastatic tumor growth in the MMTVneu model of breast cancer.
Sacco MG; Soldati S; Indraccolo S; Cató EM; Cattaneo L; Scanziani E; Vezzoni P
Gene Ther; 2003 Oct; 10(22):1903-9. PubMed ID: 14502219
[TBL] [Abstract][Full Text] [Related]
20. Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice.
Galaup A; Magnon C; Rouffiac V; Opolon P; Opolon D; Lassau N; Tursz T; Perricaudet M; Griscelli F
Gene Ther; 2005 May; 12(10):831-42. PubMed ID: 15789064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
